Expression of stabilized β-catenin in differentiated neurons of transgenic mice does not result in tumor formation

BMC Cancer

Volumn 2, Issue , 2002, Pages

  Kratz, John E ^a   Stearns, Duncan ^a   Huso, David L ^a   Slunt, Hilda H ^a   Price, Donald L ^a   Borchelt, David R ^a   Eberhart, Charles G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PHENYLALANINE; WNT PROTEIN; CATNB PROTEIN, MOUSE; CYTOSKELETON PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; ZEBRAFISH PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CARCINOGENESIS; CELLULAR DISTRIBUTION; CEREBELLUM; CODON; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PROTEIN FOLDING; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; BRAIN; BRAIN TUMOR; CELL CULTURE; CELL NUCLEUS; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CELL NUCLEUS; CELLS, CULTURED; CEREBELLUM; CYTOSKELETAL PROTEINS; GENE EXPRESSION; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; NEURONS; NUCLEAR PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSGENES; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037011776     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-2-33     Document Type: Article

References (36)

1. Taylor MD, Mainprize TG and Rutka JT Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review. Neurosurgery 2000, 47:888-901
2. Barel D, Avigad S, Mor C, Fogel M, Cohen IJ and Zaizov R A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family. Cancer Genet Cytogenet 1998, 103:1-6
3. Adesina AM, Nalbantoglu J and Cavenee WK p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res 1994, 54:5649-51
4. Raffel C, Thomas GA, Tishler DM, Lassoff S and Allen JC Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 1993, 33:301-5discussion 305-6
5. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C and Wainwright BJ Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 1999, 8:291-7
6. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P and Reifenberger G Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998, 58:1798-803
7. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, Sorensen N, Berthold F, Henk B and Schmandt N Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997, 57:2085-8
8. Lam CW, Xie J, To KF, Ng HK, Lee KC, Yuen NW, Lim PL, Chan LY, Tong SF and McCormick F A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999, 18:833-6
9. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L and Lowrance A Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002, 31:306-10
10. Goodrich LV, Milenkovic L, Higgins KM and Scott MP Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997, 277:1109-13
11. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G and Zimmer A Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998, 4:619-22
12. Wetmore C, Eberhart DE and Curran T Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001, 61:513-6
13. Peifer M Signal transduction. Neither straight nor narrow. Nature 1999, 400:213-5
14. Moon RT, Bowerman B, Boutros M and Perrimon N The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296:1644-6
15. Polakis P The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999, 9:15-21
16. Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P and Ohgaki H APC mutations in sporadic medulloblastomas. Am J Pathol 2000, 156:433-7
17. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W and Reifenberger G Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001, 93:445-9
18. Eberhart CG, Tihan T and Burger PC Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000, 59:333-7
19. Zurawel RH, Chiappa SA, Allen C and Raffel C Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 1998, 58:896-9
20. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD and Pietsch T Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001, 61:7039-43
21. Megason SG and McMahon AP A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development 2002, 129:2087-98
22. Chenn A and Walsh CA Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002, 297:365-9
23. McMahon AP and Bradley A The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990, 62:1073-85
24. Wang Y, Huso D, Cahill H, Ryugo D and Nathans J Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. J Neurosci 2001, 21:4761-71
25. Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA and Sisodia SS A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 1996, 13:159-63
26. Furlong MT and Morin PJ Rare activation of the TCF/beta-catenin pathway in ovarian cancer. Gynecol Oncol 2000, 77:97-104
27. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG and Borchelt DR Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001, 17:157-65
28. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T and Bejsovec A Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997, 88:789-99
29. Perry WL 3rd, Vasicek TJ, Lee JJ, Rossi JM, Zeng L, Zhang T, Tilghman SM and Costantini F Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics 1995, 141:321-32
30. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM and Costantini F The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-92
31. Lucas JJ, Hernandez F and Avila J Nuclear localization of beta-catenin in adult mouse thalamus correlates with low levels of GSK-3beta. Neuroreport 1999, 10:2699-703
32. Halberg RB, Katzung DS, Hoff PD, Moser AR, Cole CE, Lubet RA, Donehower LA, Jacoby RF and Dove WF Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A 2000, 97:3461-6
33. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M and Taketo MM Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. Embo J 1999, 18:5931-42
34. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, von Boehmer H, Taketo MM, Cardiff RD, Hennighausen L and Khazaie K Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A 2002, 99:219-24
35. Imbert A, Eelkema R, Jordan S, Feiner H and Cowin P Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 2001, 153:555-68
36. Fults D, Pedone C, Dai C and Holland EC MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. Neoplasia 2002, 4:32-9